Norway Non-steroidal Anti-inflammatory Drugs Market Size & Outlook
The non-steroidal anti-inflammatory drugs market in Norway is expected to reach a projected revenue of US$ 209.7 million by 2030. A compound annual growth rate of 3.9% is expected of Norway non-steroidal anti-inflammatory drugs market from 2025 to 2030.
Revenue, 2024 (US$M)
$166.5
Forecast, 2030 (US$M)
$209.7
CAGR, 2025 - 2030
3.9%
Report Coverage
Norway
Related Markets
Norway non-steroidal anti-inflammatory drugs market highlights
- The Norway non-steroidal anti-inflammatory drugs market generated a revenue of USD 166.5 million in 2024 and is expected to reach USD 209.7 million by 2030.
- The Norway market is expected to grow at a CAGR of 3.9% from 2025 to 2030.
- In terms of segment, arthritis was the largest revenue generating disease indication in 2024.
- Migraine is the most lucrative disease indication segment registering the fastest growth during the forecast period.
Non-steroidal anti-inflammatory drugs market data book summary
| Market revenue in 2024 | USD 166.5 million |
| Market revenue in 2030 | USD 209.7 million |
| Growth rate | 3.9% (CAGR from 2025 to 2030) |
| Largest segment | Arthritis |
| Fastest growing segment | Migraine |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Arthritis, Migraine, Ophthalmic Diseases |
| Key market players worldwide | Pfizer Inc, Bayer AG, GSK PLC ADR, Dr Reddy's Laboratories Ltd ADR, Viatris Inc, Teva Pharmaceutical Industries Ltd ADR, Johnson & Johnson, Merck & Co Inc |
Other key industry trends
- In terms of revenue, Norway accounted for 0.7% of the global non-steroidal anti-inflammatory drugs market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, UK non-steroidal anti-inflammatory drugs market is projected to lead the regional market in terms of revenue in 2030.
- UK is the fastest growing regional market in Europe and is projected to reach USD 1,859.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Non-steroidal Anti-inflammatory Drugs Market Scope
Non-steroidal anti-inflammatory drugs market segmentation & scope
Non-steroidal Anti-inflammatory Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Teva Pharmaceutical Industries Ltd ADR | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Merck & Co Inc | View profile | 72000 | 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 | https://www.merck.com |
| GSK PLC ADR | View profile | 70200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | https://www.gsk.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| Dr Reddy's Laboratories Ltd ADR | View profile | 22822 | 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, India, 500 034 | https://www.drreddys.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Norway non-steroidal anti-inflammatory drugs market size, by disease indication, 2018-2030 (US$M)
Norway Non-steroidal Anti-inflammatory Drugs Market Outlook Share, 2024 & 2030 (US$M)
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
